Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 17.168\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCc1nnc(SCC(=O)Nc2ccc3c(c2)OCO3)o1
b.) COc1ccc(C2=Nn3c(nnc3-c3ccncc3)SC2)cc1
c.) Cc1nccn1CCCNC(=O)CC1C(=O)NCCN1Cc1ccc(F)cc1Cl
Answer: c. Cc1nccn1CCCNC(=O)CC1C(=O)NCCN1Cc1ccc(F)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nccn1CCCNC(=O)CC1C(=O)NCCN1Cc1ccc(F)cc1Cl
Cc1nccn1CCCNC(=O)CC1C(=O)NCCN1Cc1ccc(F)cc1Cl
2-[1-[(2-chloro-4-fluorophenyl)methyl]-3-oxopiperazin-2-yl]-N-[3-(2-methylimidazol-1-yl)propyl]acetamide